Regulus Therapeutics Inc. insider trading activity

Understanding Insider Activity at Regulus Therapeutics Inc.

Welcome to our dedicated page for Regulus Therapeutics Inc. (Nasdaq: RGLS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Regulus Therapeutics Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Regulus Therapeutics Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for RGLS
TickerTime & DateFilingLink
RGLS8:18:02 PM, 7/29/2024
Collier Kathryn J purchased 4000 shares of Regulus Therapeutics Inc. (RGLS) for ~$7280
Filing
RGLS1:24:29 AM 1/19/2024
CALSADA CRISPINA(Chief Financial Officer) sold 5468 shares of Regulus Therapeutics Inc. (RGLS) for ~$6506
Filing
RGLS1:23:30 AM 1/19/2024
Aker Christopher Ray(Sr. VP & General Counsel) sold 5468 shares of Regulus Therapeutics Inc. (RGLS) for ~$6506
Filing
RGLS1:22:50 AM 1/19/2024
Hagan Joseph P(Chief Executive Officer) sold 14580 shares of Regulus Therapeutics Inc. (RGLS) for ~$17350
Filing